In silico design of human IMPDH inhibitors using pharmacophore mapping and molecular docking approaches

Computational and Mathematical Methods in Medicine
Rui-Juan LiMao-Sheng Cheng

Abstract

Inosine 5'-monophosphate dehydrogenase (IMPDH) is one of the crucial enzymes in the de novo biosynthesis of guanosine nucleotides. It has served as an attractive target in immunosuppressive, anticancer, antiviral, and antiparasitic therapeutic strategies. In this study, pharmacophore mapping and molecular docking approaches were employed to discover novel Homo sapiens IMPDH (hIMPDH) inhibitors. The Güner-Henry (GH) scoring method was used to evaluate the quality of generated pharmacophore hypotheses. One of the generated pharmacophore hypotheses was found to possess a GH score of 0.67. Ten potential compounds were selected from the ZINC database using a pharmacophore mapping approach and docked into the IMPDH active site. We find two hits (i.e., ZINC02090792 and ZINC00048033) that match well the optimal pharmacophore features used in this investigation, and it is found that they form interactions with key residues of IMPDH. We propose that these two hits are lead compounds for the development of novel hIMPDH inhibitors.

References

Sep 30, 1998·Progress in Nucleic Acid Research and Molecular Biology·A G ZimmermannB S Mitchell
Apr 5, 2001·Journal of Pharmaceutical Sciences·J JainM W Harding
Apr 20, 2002·Bioorganic & Medicinal Chemistry Letters·Henry H GuDiane Hollenbaugh
Aug 17, 2002·The Journal of Pharmacology and Experimental Therapeutics·Jugnu JainCaroline Decker
Sep 25, 2002·Bioorganic & Medicinal Chemistry Letters·Scott H WattersonEdwin J Iwanowicz
Sep 25, 2002·Transplantation Proceedings·A H MiladipourH Nejadgashti
Oct 24, 2002·Bioorganic & Medicinal Chemistry Letters·T G Murali DharEdwin J Iwanowicz
Feb 5, 2003·Bioorganic & Medicinal Chemistry Letters·Scott H WattersonEdwin J Iwanowicz
Mar 27, 2003·Bioorganic & Medicinal Chemistry Letters·Scott H WattersonEdwin J Iwanowicz
Feb 18, 2006·Bioorganic & Medicinal Chemistry Letters·Rebekah E BeeversSophie C Williams
Apr 28, 2006·Journal of Medicinal Chemistry·Curtis R ChongJun O Liu
Mar 14, 2008·Current Medicinal Chemistry·L ChenK W Pankiewicz
Aug 21, 2008·International Journal of Cancer. Journal International Du Cancer·Daniel Floryk, Timothy C Thompson
Jun 2, 2009·Chemical Reviews·Lizbeth Hedstrom
Apr 27, 2011·Current Medicinal Chemistry·L HedstromD R Gollapalli
Apr 27, 2011·Current Medicinal Chemistry·K Felczak, K W Pankiewicz
Dec 29, 2011·Journal of Molecular Modeling·Wenting TaiYadong Chen
Apr 13, 2013·Journal of Computer-aided Molecular Design·G Madhavi SastryWoody Sherman
Oct 23, 2013·Bioorganic & Medicinal Chemistry Letters·Yen-Ling WangChuan-Yi Tang
Dec 25, 2013·Antimicrobial Agents and Chemotherapy·Suresh Kumar GorlaLizbeth Hedstrom
Jan 30, 2014·Journal of Molecular Graphics & Modelling·Rahul P GangwalAbhay T Sangamwar

❮ Previous
Next ❯

Methods Mentioned

BETA
Profiler
X-ray

Software Mentioned

Discovery Studio
CHARMm
Schrödinger
DS
Vertex
glide XP

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antiparasitics

Antiparasitics are medications which are indicated for the treatment of parasitic diseases. Discover the latest research on antiparasitics here.